Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside

about

Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside

Item

http://www.wikidata.org/entity/Q37290687

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging hematological targets ...... disease: From bench to bedside

@en

Emerging hematological targets ...... isease: From bench to bedside.

@nl

type

Item

label

Emerging hematological targets ...... disease: From bench to bedside

@en

Emerging hematological targets ...... isease: From bench to bedside.

@nl

prefLabel

Emerging hematological targets ...... disease: From bench to bedside

@en

Emerging hematological targets ...... isease: From bench to bedside.

@nl

P1476

Emerging hematological targets ...... disease: From bench to bedside

@en

P2093

Ana Villegas

http://www.w3.org/2001/XMLSchema#string

Fernando A Gonzalez

http://www.w3.org/2001/XMLSchema#string

Leopoldo Llorente

http://www.w3.org/2001/XMLSchema#string

Santiago Redondo

http://www.w3.org/2001/XMLSchema#string

P2860

Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II

Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease

Atherosclerosis — An Inflammatory Disease

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Effects of aspirin on number, activity and inducible nitric oxide synthase of endothelial progenitor cells from peripheral blood

Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs

P304

397-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/BTT.S2911

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19707371

http://www.w3.org/2001/XMLSchema#string

P932

2721378

http://www.w3.org/2001/XMLSchema#string